An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
Open Access
- 7 June 2011
- journal article
- review article
- Published by Hindawi Limited in Advances in Urology
- Vol. 2011, 1-8
Abstract
Overactive bladder is a common and bothersome condition. Antimuscarinic agents, as a class, are the cornerstone of medical treatment of overactive bladder. They offer significant improvements in symptoms and patients’ quality of life. Antimuscarinics are generally well tolerated with mild and predictable side effects. Available antimuscarinics have small, yet statistically significant, differences in their efficacy and tolerability profiles. In clinical practice, finding the agent that offers the optimum balance of efficacy and side effects for an individual patient remains the major challenge.Keywords
This publication has 79 references indexed in Scilit:
- Patient‐reported reasons for discontinuing overactive bladder medicationBJU International, 2010
- Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head‐to‐head placebo‐controlled trialBJU International, 2009
- A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive BladderEuropean Urology, 2008
- Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: Results of a 12-week, multicenter, open-label, flexible-dose studyClinical Therapeutics, 2008
- Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapyInternational Journal Of Clinical Practice, 2008
- The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-AnalysisEuropean Urology, 2008
- Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacinInternational Journal Of Clinical Practice, 2008
- Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-controlled, Double-blind, Crossover Study With Tolterodine and Darifenacin in Healthy Participants ≥50 YearsJournal of Cardiovascular Pharmacology and Therapeutics, 2008
- Trospium Chloride in the Management of Overactive BladderDrugs, 2004
- Effect of oxybutynin on the QTc interval in elderly patients with urinary incontinenceBritish Journal of Clinical Pharmacology, 1996